[ad_1]
Purdue Pharma, accused of fueling the opioid crisis, filed a complaint under Chapter 11 of the RPN
Purdue Pharma, the manufacturer of OxyContin, asked Sunday for the protection of its bankruptcy in Chapter 11, just days after the conclusion of an agreement with more than 2,000 …
View full coverage on Google News
[ad_2]
Source link